Prezista - Drug Details
๐Ÿ“Š Estimates Prezista Dialyzability By Different_Modalities

Prezista

Complete Drug Information

Drug Name
Prezista
Trade Names
Prezista
Pregnancy Category
AU: B2
Bioavailability
37% (without ritonavir), 82% (with ritonavir)
Routes of Administration
Oral
Protein Binding
95%%
Metabolism
Liver (CYP3A4)
Elimination
15 hours (with ritonavir)
Excretion
Feces (80%), urine (14%)
Formula
C27H37N3O7S
Molar Mass
547.67
Drug Class
HIV protease inhibitor
Volume of Distribution
C27H37N3O7S

๐Ÿคฐ Pregnancy Category Information

Category: AU: B2

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies are inadequate or may be lacking, but available data show no evidence of an increased occurrence of fetal damage.